Barry Quart
Chief Executive Officer at CONNECT BIOPHARMA HOLDINGS LIMITED
Net worth: 836 740 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Felix Baker | M | 55 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel.
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 24 years |
| Sanj Patel | M | 54 |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | 16 years |
| Thomas Malley | M | 55 |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | 18 years |
| Mark Ragosa | M | 50 |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | 6 years |
| Stephen Biggar | M | 53 | 13 years | |
| Eben Tessari | M | 42 | 10 years | |
| Christian Waage | M | 57 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 13 years |
| Wubin Pan | M | 60 | 12 years | |
| Kim Popovits | F | 65 |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | 6 years |
| Craig Johnson | M | 62 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Adam Morgan | M | 45 | 1 years | |
| Michael Megna | M | 53 | 6 years | |
| Craig Collard | M | 58 | 1 years | |
| Zheng Wei | M | 61 | 9 years | |
| Kleanthis Xanthopoulos | M | 66 | 4 years | |
| William T. Comer | M | 85 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | 15 years |
| Susan Rodriguez | F | 60 | 3 years | |
| Chris Storgard | M | 58 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 10 years |
| Jean Liu | F | 55 | 3 years | |
| Melissa Manno | F | - | 9 years | |
| Kan Chen | M | 42 | 4 years | |
| Tracey McCain | F | 56 | 6 years | |
| Maria Z. Kounnas | M | - |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | - |
| Madelyn Zeylikman | F | - | 4 years | |
| Jiang Bian | F | - | 3 years | |
| Sharmila Dissanaike | M | 49 | 3 years | |
| Karen Wilson | F | 61 | 4 years | |
| G. Cole | M | 68 | 4 years | |
| Richard Levy | M | 66 | 5 years | |
| Rachel Frank | F | - | - | |
| Raul Collazo | M | - | 3 years | |
| Chad Morin | M | - | 4 years | |
| Ross Moat | M | 43 | 5 years | |
| John Paolini | M | 59 | 8 years | |
| Martina Struck | M | - | 6 years | |
| John C. Arthur | M | 58 | 7 years | |
| Sean T. Ristine | M | 54 | 10 years | |
| Steven Chan | M | 52 | 3 years | |
| Lei Sun | M | 60 | 4 years | |
| Charles O. Thompson | M | 67 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | 22 years |
| Zuie Chin Huang | M | 58 | - | |
| Tom Reed | M | - |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Davis | M | 63 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 13 years |
| Kevin Tang | M | 57 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 26 years |
| Kimberly Manhard | F | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 17 years |
| David Szekeres | M | 50 | 7 years | |
| John W. Poyhonen | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Henry Fuchs | M | 66 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 16 years |
| Thomas Beetham | M | 55 | 8 years | |
| Christopher Heberlig | M | 49 | 12 years | |
| Stephen Mahoney | M | 53 | 7 years | |
| Lisa Peraza | F | 47 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 16 years |
| Gregory H. Turnbull | M | 85 | 26 years | |
| Rasmus Holm-Jorgensen | M | 53 | 11 years | |
| John B. Whelan | M | 62 | 4 years | |
| Andrew L. Graham | M | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 7 years |
| Carsten Boess | M | 57 | 9 years | |
| Martin Mattingly | M | 66 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 5 years |
| Robert H. Rosen | M | 68 | 7 years | |
| Esmé c. Smith | F | 52 | - | |
| Mark Goldberg | M | 69 | 6 years | |
| Thomas Tisch | M | 69 | 3 years | |
| Jesse Hollingsworth | M | - | - | |
| Mark Longer | M | - |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA.
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 4 years |
| Wendy Dixon | M | 68 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 1 years |
| James M. Mackay | M | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 years |
| Brendan Classon | M | - | - | |
| Kristin Martin | F | 49 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | - |
| James R. Thomas | M | 73 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 2 years |
| Michael A. Adam | M | 66 | 5 years | |
| E. Lawrence Hill | M | 73 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 1 years |
| Paul Goddard | M | 74 | 12 years | |
| Kevin Kotler | M | 53 | - | |
| Peter Wirth | M | 73 | 3 years | |
| Brian Drazba | M | 63 | 4 years | |
| John W. Beck | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 years |
| Jack S. Remington | M | 93 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Daniel Ratto | M | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 1 years |
| Mark Gelder | M | 67 | 3 years | |
| Erin O’Boyle | F | - | 8 years | |
| Jeffrey Miner | M | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 years |
| Rajkumar Kannan | M | 61 | 1 years | |
| Christopher Krueger | M | 56 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 3 years |
| Anita Gupta | M | - | - | |
| Paul Barone | M | - | - | |
| Paul Blake | M | 76 | - | |
| Robert Hoffman | M | 58 | 3 years | |
| Gregory A. Grabowski | M | - | - | |
| Michael E. Mathews | M | 61 | 6 years | |
| Michael V. Greco | M | 53 | - | |
| Daniel Martin | M | 49 | 2 years | |
| Joel Schaedler | M | - | - | |
| Robert Bazemore | M | 56 | 1 years | |
| Thomas A. Pitler | M | 65 | - | |
| Glen Williams | M | 66 | - | |
| Anthony Quinn | M | 62 | 4 years | |
| Neil James Clendeninn | M | 74 | 1 years | |
| M. Harris | M | 71 |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | - |
| Paul G. Marshall | M | 64 | 3 years | |
| Arian Pano | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry Quart
- Personal Network
